Journal of Community Nutrition

The Korean Society of Community Nutrition (대한지역사회영양학회)
권호 표지

Study of Novel Markers for Early Diagnosis of Cardiovascular Diseases

  • Kang Jae Heon (Obesity Research Institute of Inje University) ;
  • Han Jung Soon (Obesity Research Institute of Inje University) ;
  • Kim Kyung A (Obesity Research Institute of Inje University) ;
  • Song Hong Ji (Obesity Research Institute of Inje University)
  • Published : 2004.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

In our country, cardiovascular disease (CVD) and Coronary heart diseases (CHD) are the leading causes of death. It is well known that CHD is multifactorial, involving environmental factors such as diet, level of exercise and cigarette smoking, and inherited factors. According to the statistical data in 2003, the cause of death with the highest mortality was including hypertension, ischemic heart disease and atherosclerosis, which accounted for $24.7\%$ of total mortality. In spite of, there have been few study reports on the change of biochemical markers and mechanisms concerned. The development of biochemical markers is required for an early diagnosis and treatment of cardiovascular diseases that are related with dietary habits of Korean people enjoying mixtures of traditional dietary style and westernized food-styles. Therefore, the most efficient cost-saving biochemical marker was established in this study, through analysis of biochemical markers related with dietary habits which are susceptibly being changed in association to cardiovascular diseases from the pre-disease phase, and through reanalysis and assessment of early diagnosis of and preventive effects of diagnosis of cardiovascular diseases by demographical character including sex, age, and socioeconomic level with use of biochemical markers that are identified and selected among the parameters in consideration of the effectiveness and appropriateness of early diagnosis of diseases. The appropriateness of biochemical markers was reviewed by professionals (medical, pharmaceutical area and food/ nutrition area) and CRP(C-Reactive Protein) and was identified to be possible in Korea. It is thought that these biochemical markers may be used as the basic data for early diagnosis and prevention of cardiovascular diseases (CVD) which may be used for Korean people.

Keywords

References

  1. Acevedo M, Pearce GL, Kottke-Marchant K, Sprecher DL(2002) Elevated fibrinogen and homocysteine levels enhancethe risk of mortality in patients from a high-risk preventive cardiology clinic.ArteriosclerThromb Vase Bioi 22 : 1042-1045 https://doi.org/10.1161/01.ATV.0000020007.25154.62
  2. Agewall S, Wikstrand J, Ljungman S, Fagerberg B (1997) : Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group.Am J Cardiol 80 : 164-169 https://doi.org/10.1016/S0002-9149(97)00312-3
  3. Alderman MH, Cohen H, Madhavan S, Kivlighn S (I999) : Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension Jul ; 34(1) : 144-150 https://doi.org/10.1161/01.HYP.34.1.144
  4. Bautista LE, Arenas lA, Penuela A, Martinez LX (2002) : Total plasma homocysteine level and risk of cardiovascular disease : a meta-analysis of prospective cohort studies. J Clin Epidemiol 55 : 882-887 https://doi.org/10.1016/S0895-4356(02)00434-1
  5. Biasucci LM, Liuzzo G, Grillo RL, Caligiuri G, Rebuzzi AG, Buffon A, Summaria F, Ginnetti F, Fedda G, Maseri A (1999) : Elevated levels of C-reactive protein at discharge in patients with unstable angina predict recurrent instability. Circulation 99 : 855-860 https://doi.org/10.1161/01.CIR.99.7.855
  6. Bogaty Ppoirier P, Simard S, Boyer L, Solymoss S, Dagenais GR (2001) : Biological profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina. Circulation 103 : 3062-3068 https://doi.org/10.1161/01.CIR.103.25.3062
  7. Cai B, Zhu Y, Ma Y, Xu Z, Zao Y, Wang J, Lin Y, Comer GM (2003) : Effect of supplementing a high-fat, low carbohydrate enteral formula in COPD patients. Nutrition 19 : 229-232 https://doi.org/10.1016/S0899-9007(02)01064-X
  8. Cantin B, Despres JP, Lamarche B, Moorjani S, Supien PJ, Bogaty P, Bergeron J, Dagenais GR (2002) : Association of fibrinogen and lipoprotein (a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study). Am J Cardiol 89 (6) : 662-666 https://doi.org/10.1016/S0002-9149(01)02336-0
  9. Christen WG, ajani UA, glynn RJ, Hennekens CH (2000) : Blood levels of homocysteine and increased risks of cardiovascular disease: causal or casual? Arch Intern Med 160 : 422-434 https://doi.org/10.1001/archinte.160.4.422
  10. Cleophas TJ, Homstra N, van Hoogstraten B, van der Meulen J (2000) : Homocysteine, a risk factor for coronary artery disease or not? a meta-analysis. Am J Cardiol 86 : 1005-1009 https://doi.org/10.1016/S0002-9149(00)01137-1
  11. Cullen P(2000) : Evidence that triglyceides are an independent coronary heart disease risk factor. Am J Cardiol 86 (9) : 943-949 https://doi.org/10.1016/S0002-9149(00)01127-9
  12. Danesh J, Collins R, Peto R (2002) : Lipoprotein (a) and coronary heart disease : meta-analysis of prospective studies. Circulation ; 102 : 1082-108535. van Exel E, Gussekloo J, de Craen AJ, Bootsma-van der Wiel A, Frolich M, Westendorp RG. Inflammation and stroke : the Leiden 85-Plus Study. Stroke 33 : 1135-1138 https://doi.org/10.1161/01.STR.0000014206.05597.9E
  13. Daniel G, Hackam, Sonia S Anand (2002) : Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288 : 2015-2022 https://doi.org/10.1001/jama.288.16.2015
  14. Di Napoli M, Papa F, Bocola V (2001) : Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 32 : 133-138 https://doi.org/10.1161/01.STR.32.1.133
  15. Fey GH, Fuller GM(]987) : Regulation of acute phase gene expression by inflammatory mediators. Mol Biol Med 4 : 323-338
  16. Folsom AR, Rosamond WD, Shahar E, et al(1999) : Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 100 : 736-742 https://doi.org/10.1161/01.CIR.100.7.736
  17. Foody JM, Milberg JA, Robinson K, Pearce GL, Jacobsen DW, Sprecher DL (2000) : Homocysteine and lipoprotein (a) interact to increase CAD risk in young men and women. Arterioscler Thromb Vasc Biol 20 : 493-499 https://doi.org/10.1161/01.ATV.20.2.493
  18. Ford ES, Smith SJ, Stroup DF, Steinberg KK, Mueller PW, Thacker SB (2002) : Homocyst (e) ine and cardiovascular disease : a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int J Epidemiol 31: 59-70 https://doi.org/10.1093/ije/31.1.59
  19. Fowkes FG(1995) : Fibrinogen and peripheral arterial disease. Eur Heart J 16 (suppl A) : 36-40 https://doi.org/10.1093/eurheartj/16.suppl_A.36
  20. Friedewald WT, Levy RI, Frederickson DS (I972) : Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chern 18 : 499-502
  21. Hart RW, Dixit R, Seng J, Turturro A, Leakey JEA, Feures R, Duffy P, Buffington C, Cowan G, Lewis S, Pipkin J,Li SY(I999) : Adaptive role of caloric intake on the degenerative disease processes. Toxicological Sciences 52 : 3-12 https://doi.org/10.1093/toxsci/52.suppl_1.3
  22. Heeschen C, Hamm CW, Bruemmer J, 'Simoons ML(2000) : Predictive value of C-reactive protein and troponin T in patients with unstable angina : a comparative analysis. J Am of Cardiol 35 : 1535-1542 https://doi.org/10.1016/S0735-1097(00)00581-7
  23. Hoffmeister A, Rothenbacher D, Banzer U, Frchlich M, Brenner M, Hombach V, Koenig W (2001) : Role of novel markers of inflammation in patients with stable coronary heart disease. Am J of Cardiol 87 (3) : 262-266 https://doi.org/10.1016/S0002-9149(00)01355-2
  24. Jager A, Kostense PJ, Ruhe HG, Heine RJ, Nijpels G, Dekker JM, Bouter LM, Stehouwer CD (1999) : Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects : five-year follow-up of the Hoom Study. Arterioscler Thromb Vasc BioI Mar 19(3) : 617-624 https://doi.org/10.1161/01.ATV.19.3.617
  25. Jensen JS, Feldt-Rasmussen B, Strandgaard S, Schroll M, BorchJohnsen (2000) : Arterial hypertension, microalbuminuria, and risk of ischemic heart disease. Hypertension 35 : 898-903 https://doi.org/10.1161/01.HYP.35.4.898
  26. Kelly PJ, Rosand J, Kistler JP, Shih VE, Silveria S, Plomaritoglou A, Furie KL (2002) : Homocysteine, MTHFR 677CT polymorphism, and risk of ischemic stroke : results of a meta-analysis. Neurology 59 : 529-536 https://doi.org/10.1212/WNL.59.4.529
  27. Kim KS, Ryn SY, Park J, Park JK, Kim CB, Chun BY, Lee TY, Lee KS, Lee DH, Koh KW, Jee SH, Suh I, for Korean Research Group for Cardiovascular Disease Prevention and Control (2001) : A nested case control study on risk factors for coronary heart disease in Korean. Korea J Prey Med 34 : 149-156
  28. Kim JH, Jeong MH, Sim DS, Lee SH, Hong YJ, Park OY, Kim W, Rhew JY, Ahn YK, Cho JG, Suh SP, Park JC, Kang JC (2002) : The usefulness of cardiac troponin as a marker for the detection of minor myocardial injury following percutaneous coronary intervension, Korean Circulation J 32 : 413-419 https://doi.org/10.4070/kcj.2002.32.5.413
  29. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG (2002) : MTHFR 677CT polymorphism and risk of coronary heart disease: a meta-analysis. JAMA 288 : 2023-2031 https://doi.org/10.1001/jama.288.16.2023
  30. Kushner I, Sehgal AR (2002) : Is high-sensitivity C-reactive protein an effective screening test for cardiovascular risk? Arch Intern Med 162 : 867-869 https://doi.org/10.1001/archinte.162.8.867
  31. Luepker RV, Apple FS, Christenson RH, Crow RS, Fortmann SP, Goff D, Goldberg RJ, Hand MM, Jaffe AS, Julian DGm, Levy D, Levy D, Manolio T, Mendis S, Mensah G, Pajak A, Prineas RJ, Reddy KS, Roger VL, Rosamon WD, Shahar E, Sharret AR, Sorlie P, Tunstall-Pedoe H ; AHA council on epidemiology and Prevention ; AHA Statistics Committee ; World Heart Federation Council on Epidemiology and Prevention ; European society of Cardiology Working Group on Epidemiology and Prevention ; Centers for Disease Control and Prevention ; National Heart, Lung, and Blood Institute. (2003) : Case definitions for acute coronary heart disease in epidemiology and clinical research studies : a statement from the AHA Council on Epidemiology and Prevention ; AHA Statistics Committee ; World Heart Federation Council on Epidemiology and Prevention; The Eropean Society of Cariology Working Group on Epidemiology and prevention ; Centers for Disease Control and Prevention ; and the National Heart Lung, and Blood institute. Circulation 108 : 2543-2549 https://doi.org/10.1161/01.CIR.0000100560.46946.EA
  32. Maresca G, Di Blasio A, Marchioli R, Di Minno G(1999) : Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. Arterioscler Thromb Vasc Biol 19 : 1368-1377 https://doi.org/10.1161/01.ATV.19.6.1368
  33. Meade TW, Imeson J, Stirling Y (1987) : Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease. Lancet 2 : 986-988
  34. Moller J, Nielsen GM, Tvedegaard KC, Andersen NT, Jorgensen PE (2000) : A meta-analysis of cerebrovascular disease and hyperhomocysteinaemia, Scand J Clin Lab Invest 60 : 491-499 https://doi.org/10.1080/003655100448473
  35. Muir KW, Weir CJ, Alwan W, Squire IB, Lees KR(1999) : C-reactive protein and outcome after ischemic stroke. Stroke 30 : 981-985 https://doi.org/10.1161/01.STR.30.5.981
  36. Murry CJ, Lopez AD (1997) : Mortality by cause for eight regions of the world : Global Burden of disease study. Lancet 349 : 1269-1279 https://doi.org/10.1016/S0140-6736(96)07493-4
  37. National Institutes of Health National Heart, Lung and Blood Institute (1995) : Recommendations on lipoprotein measurement. From the working Group on Lipoprotein Measurement. National Cholesterol Education Program, pp.20-21
  38. Park MJ, Kim HT, Park SY, Lee KS (1997) : Evalulation of diagnostic efficiency of Troponin T measurement in acute myocardial infarction and ischemic heart disease. Korean J Clin Pathol 17 : 560-568
  39. Pasceri V, Willerson JT, Yeh ET(2000) : Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102 : 2165-2168 https://doi.org/10.1161/01.CIR.102.18.2165
  40. Ridker PM, Rifai N, Stampfer MJ, Heunekens CM (2000) : Plasma concentration of Interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101 : 1767-1772 https://doi.org/10.1161/01.CIR.101.15.1767
  41. Rifai N, Ridker PM (2002) : Inflammatory markers and coronary heart disease. Current Opinion in Lipidology 13 : 383-389 https://doi.org/10.1097/00041433-200208000-00005
  42. Ridker PM (1999) : Evaluating novel cardiovascular risk factors : can we better predict heart attacks? Ann Int Med 130 : 933-937 https://doi.org/10.7326/0003-4819-130-11-199906010-00018
  43. Schnyder G, Roffi M, Pin R, Hess OM (2001) : Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 345 : 1593-1600 https://doi.org/10.1056/NEJMoa011364
  44. Schnyder G, Roffi M, Flammer Y, Pin R, Hess OM (2002) : Effect of homocysteine-lowering therapy with folic acid vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention : The Swiss Heart study : a randomized controlled trial. JAMA 288 : 973-979 https://doi.org/10.1001/jama.288.8.973
  45. Solfrizzi V, Panza F, Colacicco AM, Capurso C, D'Introno A, Torres F, Baldassare G, Capurso A (2002) : Relation of lipoprotein (a) as coronary risk factor to type 2 diabetes mellitus and lowdensity lipoprotein cholesterol in patients> or=65 years of age (The Italian Longitudinal Study on Aging) . Am J Cardiol 89 : 825-829 https://doi.org/10.1016/S0002-9149(02)02192-6
  46. Tanne D, Benderly M, Goldbourt U, Boyko V, Brunner D, Graff E, Reicher-Reiss H, Shotan A Mandelzweig L, Behar S, Bezafibrate Infarciton Prevention Study Group (2001) : A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention study. Am J Med 111 : 457-463 https://doi.org/10.1016/S0002-9343(01)00914-7
  47. Tommasi S, Carluccio E, Bentivoglio M, Buccolieri M, Mariotti M (1999) : C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction. Am J Cardiol 83 : 1595-1599 https://doi.org/10.1016/S0002-9149(99)00162-9
  48. Torzewski J, Torzewski M, Bowyer DE, Politano M, Corea L (1998) : C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 18 : 1386-1392 https://doi.org/10.1161/01.ATV.18.9.1386
  49. Torzewski M, Rist C, Mortensen RF, Fronlich M, Koenig W, Waltenberger J, Fitzsinnons C, Hombach V (2000) : C-reactive protein in the arterial intima : role of C-reactive protein receptordependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 20 : 2094-2099 https://doi.org/10.1161/01.ATV.20.9.2094
  50. U.S. Preventive Service Task Force (2001) : Screening and treating adults for lipid disorders- Recommendation and rationale. AM J Prev Med 20 (3S) : 73-76. Available from: URL : http:// www.ahcpr.gov/clinic/upsetf/uspschol.htm https://doi.org/10.1016/S0749-3797(01)00266-5
  51. Van Exel E, Gussekloo J, de Craen AJ, Bootsma-van der Wiel A, Frolich M, Westendorp RG (2002) : Inflammation and stroke : the Leiden 85-Plus Study. Stroke 33 : 1135-1138 https://doi.org/10.1161/01.STR.0000014206.05597.9E
  52. Verma S, Li SH, Badiwala MY, Weisel RD, Fedak PW, Ki RK, Dhillon Bm Mickle DA (2002) : Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of c-reactive protein. Circulation 105 : 1890-1896 https://doi.org/10.1161/01.CIR.0000015126.83143.B4
  53. Von Eckardstein A, Schulte H, Cullen P, Assmann G (2001) : Lipoprotein (a) further increases the risk of coronary events in men with high global cardiovascular risk. J Am Coll Cardiol 37 : 434-439 https://doi.org/10.1016/S0735-1097(00)01126-8
  54. Wald DS, Law M, Morris JK (2002) : Homocysteine and cardiovascular disease : evidence on causality from a meta-analysis. BMJ 325 : 1202-1210 https://doi.org/10.1136/bmj.325.7374.1202
  55. Weintraub WS, Harrison DG(2000) : C-reactive protein, inflammation and atheroscleerosis : do we really understand it yet? Eur Heart J 21 : 958-960 https://doi.org/10.1053/euhj.2000.2109
  56. Weir CJ, Muir SW, Walters MR, Lees KR (2003) : Serum uric acid as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke Aug 34 (8) : 1951-1956 https://doi.org/10.1161/01.STR.0000081983.34771.D2
  57. Wilkes HC, Kelleher C, Meade TW (1988) : Smoking and plasma fibrinogen. Lancet 1:307-308
  58. Wilson PW, D' Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) : Prediction of coronary heart disease using risk factor categories. Circulation 97 : 1837-1847 https://doi.org/10.1161/01.CIR.97.18.1837
  59. World Health Organization (2004) ; The World Health Report 2002. Available at : http://www.who.intlwhr/en/Accessibility verified January 15
  60. Zwaka TP, Hombach V, Torzewski J (2003) : C-reactive protein-mediated low density lipoprotein uptake by macrophages : implications for atherosclerosis. Circulation 103 : 1194-1197